Bryant Guffey, MBA ’10 (left) and George K. Lewis Jr., MS ’08, PhD ’12, co-founders, ZetrOZ
Wowing skeptics with miniature therapeutics
Now, more than 200 ZetrOZ systems are being used for veterinary rehabilitation, and the company boasts three executives on the management team, three full-time engineers, and a national sales and distribution network.
ZetrOZ products are based on Lewis’ innovative designs in ultrasonics on a miniature scale. Ironically, it was this very novelty that caused the biggest challenge in the beginning. “Few people believed that a couple of young guys starting a company out of school could really build medical devices to rival those of the much larger, established companies,” says Guffey.
But ZetrOZ’s track record with veterinary applications has attracted serious attention. The company is currently seeking U.S. FDA approval for a human version of the device to treat arthritis and tendonitis, and to speed post-operative recovery. “We’re now closing our Series-A round of financing to allow us to scale the rehab product line into the human world,” says Guffey. ZetrOZ has also been engaged by larger companies to integrate its novel technology into pill-sized ultrasound systems and even a new system to treat deep vein thrombosis.
ZetrOZ has received invaluable help from the Cornell Center for Technology Enterprise and Commercialization, the Cornell athletic department, and from Cornell and Johnson alumni. “The Johnson and Cornell alumni are some of the best in the world,” says Guffey. “I have rarely run into an alumnus, even the busiest, who wouldn’t at least take a call or answer an email.”